BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 16676272)

  • 1. Macrophage migration inhibitory factor as a therapeutic target after traumatic spinal cord injury: a systematic review.
    Piri SM; Ghodsi Z; Shool S; Anjomshoa A; Azarhomayoun A; Jangholi E; Dehghan HR; Atlasi R; Vaccaro AR; Rahimi-Movaghar V
    Eur Spine J; 2021 Jun; 30(6):1474-1494. PubMed ID: 33486594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses.
    Orr MB; Gensel JC
    Neurotherapeutics; 2018 Jul; 15(3):541-553. PubMed ID: 29717413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia.
    Silver J; Schwab ME; Popovich PG
    Cold Spring Harb Perspect Biol; 2014 Dec; 7(3):a020602. PubMed ID: 25475091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.
    Donnelly DJ; Popovich PG
    Exp Neurol; 2008 Feb; 209(2):378-88. PubMed ID: 17662717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of immunomodulation with human interferon-beta on early functional recovery from experimental spinal cord injury.
    Gok B; Okutan O; Beskonakli E; Palaoglu S; Erdamar H; Sargon MF
    Spine (Phila Pa 1976); 2007 Apr; 32(8):873-80. PubMed ID: 17426631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of clinical trials for acute spinal cord injury.
    Fehlings MG; Baptiste DC
    Injury; 2005 Jul; 36 Suppl 2():B113-22. PubMed ID: 15993112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis and treatment of acute spinal cord injuries in dogs.
    Olby N
    Vet Clin North Am Small Anim Pract; 2010 Sep; 40(5):791-807. PubMed ID: 20732592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug evaluation: ProCord - a potential cell-based therapy for spinal cord injury.
    Kigerl K; Popovich P
    IDrugs; 2006 May; 9(5):354-60. PubMed ID: 16676272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological approaches to repair the injured spinal cord.
    Baptiste DC; Fehlings MG
    J Neurotrauma; 2006; 23(3-4):318-34. PubMed ID: 16629619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for neuroprotection following spinal cord injury.
    Tederko P; Krasuski M; Kiwerski J; Nyka I; BiaƂoszewski D
    Ortop Traumatol Rehabil; 2009; 11(2):103-10. PubMed ID: 19502667
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.